Gil Hakim, CEO

Gil Hakim brings over 20 years of experience in the life sciences industry, with a proven track record of identifying promising early-stage concepts across diverse fields and devising the optimal strategy for bringing them to market, having previously worked for Urogen Pharma (NASDAQ: URGN). Mr. Hakim holds a B.Sc. in Life Sciences from Ben Gurion University of the Negev.